NCT01552434 2025-10-14
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
Clinical Trials
6 trialsNCT00728663 2019-05-14
Docetaxel and Cetuximab in Treating Patients With Metastatic Prostate Cancer
Swiss Cancer Institute
Phase 2 Completed
NCT00622674 2017-12-02
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
Masonic Cancer Center, University of Minnesota
Phase 1 Completed
NCT00350025 2017-03-31
Study of Cetuximab With and Without Weekly Paclitaxel for Patients With Previously Treated Advanced Urothelial Cancer
Fox Chase Cancer Center
Phase 2 Completed
NCT00645593 2016-05-23
Study of Gemcitabine and Cisplatin With or Without Cetuximab in Urothelial Cancer
University of Michigan Rogel Cancer Center
Phase 2 Completed
NCT00448097 2016-03-17
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy
The Methodist Hospital Research Institute
Phase 2 Terminated